See our latest analysis for Paramount Group.
Paramount Group’s 32% year-to-date share price return has caught attention, especially as investors respond to mounting signs of stabilization across real estate. While total shareholder return over the past year lands at a robust 38%, the longer-term five-year figure still reflects the sector’s challenges and sits noticeably in the red. For now, short-term momentum appears to be building off recent gains and hints at brighter sentiment compared to the past several years.
If Paramount’s recent move has you wondering what else could be gathering pace, now is the perfect time to discover fast growing stocks with high insider ownership
With shares up significantly this year but trading just below the average analyst price target, investors may be asking if Paramount Group is currently undervalued or if the latest gains already reflect future growth. Is there a true buying opportunity, or is the market one step ahead?
Price-to-Sales of 2.1x: Is it justified?
Paramount Group currently trades at a price-to-sales (P/S) ratio of 2.1x, which matches the US Office REITs industry average but is higher than its peer group average of 1.8x. With shares closing at $6.57, the stock appears relatively expensive when measured by this metric.
The price-to-sales ratio compares a company’s market value to its total revenue and is often used to judge valuations within real estate investment trusts where profitability may be variable. For Paramount Group, a higher P/S indicates investors are paying a premium for each dollar of revenue generated.
Compared to industry peers, Paramount’s P/S multiple not only aligns with the sector average but also exceeds its closest competitors. Despite this, the fair price-to-sales ratio for the company is estimated at 2.4x. The market could move toward this level if sentiment improves or if the business delivers stronger revenues than anticipated.
Explore the SWS fair ratio for Paramount Group
Result: Price-to-Sales of 2.1x (ABOUT RIGHT)
However, weakening annual revenue and declining net income growth could challenge Paramount’s momentum, especially if broader real estate headwinds become more significant.
Find out about the key risks to this Paramount Group narrative.
Another View: SWS DCF Model Suggests Overvaluation
While the price-to-sales ratio presents a picture of moderate valuation, our SWS DCF model offers a different perspective. According to this approach, Paramount Group’s estimated fair value is just $0.44 per share, which is far below its current trading level. This suggests the stock may be significantly overvalued if you prioritize cash flow fundamentals over multiples. Is the market thinking too far ahead, or is there more to the story?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Paramount Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 926 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Paramount Group Narrative
If this perspective does not match your own outlook or you want to dig into the details directly, you can build a custom narrative for yourself in just a few minutes, so why not Do it your way
A great starting point for your Paramount Group research is our analysis highlighting 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
There is a world of opportunity beyond Paramount Group, from the next tech breakout to tomorrow’s best dividend payers. Stay ahead—smart moves start with Simply Wall Street’s handpicked selections.
- Pinpoint strong cash flow potential by evaluating the best picks through these 926 undervalued stocks based on cash flows.
- Secure your future income streams by checking out these 16 dividend stocks with yields > 3% that offer yields above 3%.
- Ride the cutting edge of healthcare innovation by reviewing these 30 healthcare AI stocks poised to transform the industry.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Paramount Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com